EcoDrugPlus

Ensembl ID : YAL022C
Description: -
140 Possible Orthologues:

Title

Ensembl ID : YAL060W
Description: -
864 Possible Orthologues:

Title

Ensembl ID : YAL061W
Description: -
864 Possible Orthologues:

Title

Ensembl ID : YBL019W
Description: -
139 Possible Orthologues:

Title

Ensembl ID : YBL027W
Description: -
121 Possible Orthologues:

Title

Ensembl ID : YBL041W
Description: -
110 Possible Orthologues:

Title

Ensembl ID : YBL068W-A
Description: -
1593 Possible Orthologues:

Title

Ensembl ID : YBL069W
Description: -
1593 Possible Orthologues:

Title

Ensembl ID : YBL072C
Description: -
114 Possible Orthologues:

Title

Ensembl ID : YBL087C
Description: -
117 Possible Orthologues:

Title

Ensembl ID : YBL092W
Description: -
111 Possible Orthologues:

Title

Ensembl ID : YBR028C
Description: -
166 Possible Orthologues:

Title

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).